Provenienza dei contatti di primo grado di Paul J. Carter
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
University of Cambridge
342
| College/University | Other Consumer Services | 342 |
60
| Public Company | Pharmaceuticals: Major | 60 |
27
| Subsidiary | Pharmaceuticals: Major | 27 |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation
17
| Subsidiary | Biotechnology | 17 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Paul J. Carter tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing General Counsel | |
| PDL BIOPHARMA, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| University of California, Los Angeles | College/University | Graduate Degree Masters Business Admin Doctorate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Virginia | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| CELGENE | Biotechnology | Director of Finance/CFO President | |
| CHINOOK THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| National University of Singapore | College/University | Masters Business Admin Graduate Degree | |
| Anderson School of Management | College/University | Masters Business Admin Masters Business Admin | |
| Loyola University of Chicago | College/University | Undergraduate Degree Doctorate Degree | |
Keppel DC REIT Management Pte Ltd.
 Keppel DC REIT Management Pte Ltd. Real Estate Investment TrustsFinance Keppel DC REIT Management Pte Ltd. operates as a manager of real estate investment trust. It invests, directly or indirectly, in a diversified portfolio of income-producing real estate assets which are used primarily for data centre purposes, as well as real estate related assets, with an initial focus on Asia Pacific and Europe. The company was founded in 2008 and is headquartered in Singapore. | Real Estate Investment Trusts | Director/Board Member Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| KEPPEL DC REIT | Real Estate Investment Trusts | Director/Board Member Director/Board Member | |
| FORTE BIOSCIENCES, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Director/Board Member Founder | |
| Vanderbilt University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Chroma Medicine, Inc.
 Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| SINGAPORE PRESS HOLDINGS LIMITED | Real Estate Investment Trusts | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of Cardiff | College/University | Undergraduate Degree Undergraduate Degree | |
Oakfield Capital Partners LLP
 Oakfield Capital Partners LLP Investment ManagersFinance Oakfield Capital Partners LLP (Oakfield Capital Partners) is a private equity firm founded in 2008 by Roy Merritt and Michael Patton. The firm is headquartered in Richmond, United Kingdom. | Investment Managers | Founder Founder | |
Ingresso Group Ltd.
 Ingresso Group Ltd. Packaged SoftwareTechnology Services Ingresso Group Ltd. provides ticketing software. It offers technology-centric ticket distribution, sales and marketing services to venues, promoters, online retailers and ticket agencies. Ingresso Group was founded in January 2011 and is headquartered in London, the United Kingdom. | Packaged Software | Chairman Director/Board Member | |
Noden Pharma DAC
 Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The Gainsborough Silk Weaving Co. Ltd.
 The Gainsborough Silk Weaving Co. Ltd. TextilesProcess Industries The Gainsborough Silk Weaving Co. Ltd. produces fabrics for palaces and state buildings. The company was founded by Reginald Warner in 1903 and is headquartered in Suffolk, the United Kingdom. | Textiles | Director/Board Member Director/Board Member | |
Noden Pharma USA, Inc.
 Noden Pharma USA, Inc. Electronic Equipment/InstrumentsElectronic Technology Noden Pharma USA, Inc. is engaged in manufacturing and commercialization of filled and finished medicine products. The company is headquartered in Orlando, FL. | Electronic Equipment/Instruments | President Director/Board Member | |
The Edward Alexander Group Ltd.
 The Edward Alexander Group Ltd. Engineering & ConstructionIndustrial Services The Edward Alexander Group Ltd. provides architectural services. The British company was founded in 2017. Mark David Ellis Nevill has been the CEO of the company since 2019. | Engineering & Construction | Director/Board Member Director/Board Member | |
| The University of Southampton | College/University | Corporate Officer/Principal Graduate Degree | |
| Yale University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| M1 LIMITED | Wireless Telecommunications | Director/Board Member Director/Board Member | |
| University of London | College/University | Corporate Officer/Principal Doctorate Degree | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| State University of New York at Buffalo | College/University | Doctorate Degree Masters Business Admin | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Director of Finance/CFO | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member President | |
| University of California, Davis | College/University | Corporate Officer/Principal Doctorate Degree | |
| COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| UCLA Anderson School of Management | College/University | Masters Business Admin Corporate Officer/Principal | |
| SANA BIOTECHNOLOGY, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 35 |
| Regno Unito | 9 |
| Singapore | 6 |
| Francia | 2 |
| Canada | 2 |
Settori
| Consumer Services | 20 |
| Health Technology | 19 |
| Finance | 7 |
| Commercial Services | 3 |
| Technology Services | 2 |
Posizioni
| Director/Board Member | 690 |
| Corporate Officer/Principal | 250 |
| Independent Dir/Board Member | 182 |
| Undergraduate Degree | 86 |
| Graduate Degree | 74 |
Contatti più connessi
| Insiders | |
|---|---|
| Thieng Hwi Pang | 71 |
| Wing Yan Lo | 56 |
| Srini Akkaraju Akkaraju | 54 |
| Teck Huat Tan | 47 |
| Franklin Berger | 41 |
| Frank J. Biondi | 36 |
| Thomas Daniel | 35 |
| Huan Ping Low | 29 |
| Felix Baker | 28 |
| Hwee Hua Lim | 26 |
| Manu Bhaskaran | 25 |
| Douglas Williams | 25 |
| Daniel Welch | 24 |
| Khaled Asad Nasr | 23 |
| Chi Keung Lau | 22 |
- Borsa valori
- Insiders
- Paul J. Carter
- Connessioni Società